A trial design to maximize knowledge of the effects of rodatristat ethyl in the treatment of pulmonary arterial hypertension (ELEVATE 2)

por Lazarus, Howard M., Denning, Jill, Wring, Stephen, Palacios, Michelle, Hoffman, Sidra, Crizer, Katelyn, Kamau‐Kelley, Watiri, Symonds, William, Feldman, Jeremy
Publicado 2022

Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis

por Lawitz, Eric, Poordad, Fred, Brainard, Diana M, Hyland, Robert H, An, Di, Dvory-Sobol, Hadas, Symonds, William T, McHutchison, John G, Membreno, Fernando E
Publicado 2015

Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection

por White, Ian R, Patel, Keyur, Symonds, William T, Dev, Anouk, Griffin, Philip, Tsokanas, Nikos, Skehel, Mark, Liu, Chiang, Zekry, Amany, Cutler, Paul, Gattu, Mahanandeeshwar, Rockey, Don C, Berrey, Michelle M, McHutchison, John G
Publicado 2007

Factors in AIDS Dementia Complex Trial Design: Results and Lessons from the Abacavir Trial

por Brew, Bruce J, Halman, Mark, Catalan, Jose, Sacktor, Ned, Price, Richard W, Brown, Steve, Atkinson, Hamp, Clifford, David B, Simpson, David, Torres, Gabriel, Hall, Colin, Power, Christopher, Marder, Karen, Arthur, Justin C. Mc, Symonds, William, Romero, Carmen
Publicado 2007